Association of the RAVER2 gene with increased susceptibility for ulcerative colitis

Human Immunology

Volumn 73, Issue 7, 2012, Pages 732-735

  Bouzid, D ^a   Fourati, H ^a   Amouri, A ^b   Marques, I ^c   Abida, O ^a   Haddouk, S ^a   Ben Ayed, M ^a   Tahri, N ^b   Penha Goncalves C ^c   Masmoudi, H ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b HEDI CHAKER HOSPITAL   (Tunisia)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

POLYPYRIMIDINE TRACT BINDING PROTEIN; RAVER2 PROTEIN; RIBONUCLEOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; COHORT ANALYSIS; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TUNISIA; ULCERATIVE COLITIS;

ADULT; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNISIA;

EID: 84862308339     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.04.018     Document Type: Article

References (43)

1. Wang E.T., Sandberg R., Luo S., Khrebtukova I., Zhang L., Mayr C., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 2008, 456:470-476.
2. Baralle D., Lucassen A., Buratti E. Missed threads. The impact of pre-mRNA splicing defects on clinical practice. EMBO Rep 2009, 10:810-816.
3. Nissim-Rafinia M., Kerem B. The splicing machinery is a genetic modifier of disease severity. Trends Genet 2005, 21:480-483.
4. Raponi M., Baralle D. Alternative splicing: good and bad effects of translationally silent substitutions. FEBS J 2010, 277:836-840.
5. Deshmukh H., Kim-Howard X., Nath S.K. Replication of recently identified associated SNPs from 6 autoimmune diseases in GAW16 RA data. BMC Proc 2009, 3(Suppl. 7):S31.
6. Lettre G., Rioux J.D. Autoimmune diseases: insights from genome-wide association studies. Hum Mol Genet 2008, 17:R116-R121.
7. Black D.L. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 2003, 72:291-336.
8. Chen M., Manley J.L. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009, 10:741-754.
9. Glisovic T., Bachorik J.L., Yong J., Dreyfuss G. RNA-binding protein and post- translational gene regulation. FEBS Lett 2008, 582:1977-1986.
10. Licatalos D.D., Darnell R.D. RNA processing and its regulation: global insights into biological networks. Nat Genet 2010, 11:75-87.
11. Wahl M.C., Will C.L., Luhmann R. The spliceosome: design principles of a dynamic RNP machine. Cell 2009, 136:701-718.
12. Hallegger M., Llorian M., Smith C.W. Alternative splicing: global insights. FEBS J 2010, 277:856-866.
13. Long J.C., Caceres J.F. The SR protein family of splicing factors: master regulators of gene expression. Biochem J 2009, 417:15-27.
14. Krecic A.M., Swanson M.S. HnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 1999, 11:363-371.
15. Carpenter B., MacKay C., Alnabulsi A., MacKay M., Telfer C., Melvin W.T., et al. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006, 1765:85-100.
16. Kleinhenz B., Fabienke M., Swiniarski S., Wittenmayer N., Kirsch J., Jockusch B.M., et al. Raver2, a new member of the hnRNP family. FEBS Lett 2005, 579:4254-4258.
17. Huttelmaier S., Illenberger S., Grosheva I., Rudiger M., Singer R.H., Jockusch B.M. Raver1, a dual compartment protein, is a ligand for PTB/hnRNPI and microfilament attachment proteins. J Cell Biol 2001, 155:775-786.
18. Gromak N., Rideau A., Southby J., Scadden A.D., Gooding C., Huttelmaier S., et al. The PTB interacting protein raver1 regulates alpha-tropomyosin alternative splicing. EMBO J 2003, 22:6356-6364.
19. Rideau A.P., Gooding C., Simpson P.J., Monie T.P., Lorenz M., Huttelmaier S., et al. A peptide motif in Raver1 mediates splicing repression by interaction with the PTB RRM2 domain. Nat Struct Mol Biol 2006, 13:6356-6364.
20. Romanelli M.G., Lorenzi P., Diani E., Filippello A., Avesani F., Morandi C. Transcriptional regulation of the human Raver2 ribonucleoprotein gene. Gene 2011, [Epub ahead of print].
21. Podolsky D.K. Inflammatory bowel disease (1). N Engl J Med 1991, 325:928-937.
22. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward and integrated clinical, molecular and serological classification of inflammatory bowel disease Report of a working party of the 2005 Monteral World Congress of Gastroenterology. Can J Gastroenterol 2005, 19(Suppl. A):5-36.
23. Bouzid D., Fourati H., Amouri A., Marques I., Abida O., Haddouk S., et al. The CREM gene is involved in genetic predisposition to inflammatory bowel disease in the Tunisian population. Hum Immunol 2011, 72:1204-1209.
24. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1999, 42:585.
25. Maier L.M., Hafler D.A. The developing mosaic of autoimmune disease risk. Nat Genet 2008, 40:131-132.
26. Henneberg B., Swiniarski S., Becke S., Illenberger S. A conserved peptide motif in Raver2 mediates its interaction with the polypyrimidine tract-binding protein. Exp Cell Res 2010, 16:966-979.
27. Li Q., Lee J.A., Black D.L. Neuronal regulation of alternative pre-mRNA splicing. Nat Rev Neurosci 2007, 8:819-831.
28. Lou H., Gagel R.F., Berget S.M. An intron enhancer recognized by splicing factors activates polyadenylation. Genes Dev 1996, 10:208-219.
29. Cote C.A., Gautreau D., Denegre J.M., Kress T.L., Terry N.A., et al. AXenopus protein related to hnRNP I has a role in cytoplasmic RNA localization. Mol Cell 1999, 4:431-437.
30. Kaminski A., Hunt S.L., Patton J.G., Jackson R.J. Direct evidence that polypyrimidine tract binding protein (PTB) is essential for internal initiation of translation of encephalomyocarditis virus RNA. RNA 1995, 1:924-938.
31. Yang J., Chan C.Y., Jiang B., Yu X., Zhu G.Z., Chen Y., et al. hnRNP I inhibits Notch signaling and regulates intestinal epithelial homeostasis in the zebrafish. PLoS Genet 2009, 5:e1000363.
32. Radtke F., Clevers H., Riccio O. From gut homeostasis to cancer. Curr Mol Med 2006, 6:275-289.
33. Crosnier C., Vargesson N., Gschmeissner S., Ariza-McNaughton L., Morrison A., et al. Delta-Notch signalling controls commitment to a secretory fate in the zebrafish intestine. Development 2005, 132:1093-1104.
34. Chiba S. Notch signaling in stem cell systems. Stem Cells 2006, 24:2437-2447.
35. Jensen J., Pedersen E.E., Galante P., Hald J., Heller R.S., et al. Control of endodermal endocrine development by Hes-1. Nat Genet 2000, 24:36-44.
36. Yang Q., Bermingham N.A., Finegold M.J., Zoghbi H.Y. Requirement of Math1 for secretory cell lineage commitment in the mouse intestine. Science 2001, 294:2155-2158.
37. Lee C.S., Perreault N., Brestelli J.E., Kaestner K.H. Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev 2002, 16:1488-1497.
38. Steiner G., Skriner K., Hassfeld W., Smolen J.S. Clinical and immunological aspects of autoantibodies to RA33/hnRNP-A/B proteins - a link between RA, SLE and MCTD. Mol Biol Rep 1996, 23(3-4):167-171. [Review].
39. Jensen L., Kuff E.L., Wilson S.H., Steinberg A.D., Klinman D.M. Antibodies from patients and mice with autoimmune diseases react with recombinant hnRNP core protein A1. J Autoimmun 1988, 1:73-83.
40. Skriner K., Hueber W., Suleymanoglu E., Hofler E., Krenn V., Smolen J., et al. AUF1, the regulator of tumor necrosis factor messenger RNA decay, is targeted by autoantibodies of patients with systemic rheumatic diseases. Arthritis Rheum 2008, 58:511-520.
41. Lin T.Y., Chan L.C., Fan Y.H., Lin C.H., Chow K.C., Lin S.L., et al. Use of a recombinant protein containing major epitopes of hnRNP G to detect anti-hnRNP G antibodies in dogs with systemic lupus erythematosus. Res Vet Sci 2006, 81:335-339.
42. Montecucco C., Caporali R., Cobianchi F., Biamonti G. Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis. Arthritis Rheum 1996, 39:1669-1676.
43. Van den Bergh K., Hooijkaas H., Blockmans D., Westhovens R., Op De Beeck K., Verschueren P., et al. Heterogeneous nuclear ribonucleoprotein H1, a novel nuclear autoantigen. Clin Chem 2009, 55:946-954.